News of Note—HPV vaccination, Imutex's universal flu shot and more

non
In this week's news of note, healthcare providers are found to recommend HPV vaccine more often to girls than boys. (Pixabay)

Here is some other vaccine news of note for the week:

> A recent study found that healthcare providers are not recommending HPV vaccination to boys as often as to girls. ABC News article

> British firm Imutex’s universal flu vaccine candidate Flu-v turned in positive clinical results and could be available on England's NHS in two years. Daily Mail article

Survey

Survey: The Critical Role of Innovation in Launching Successful OTC Products

This research aims to understand the importance of product innovation and dose forms in driving new product design and development, consumer engagement and purchase interest for Over-the-Counter medicines. The first 50 qualified respondents will receive a $5 Amazon gift card. Take the survey now.

> Altimmune announced positive data from a phase 2a study of its monovalent NasoVAX intranasal flu vaccine. Results showed 100% seroprotection in the mid- and high-dose groups. Release

Suggested Articles

After countless headlines from a Dengvaxia safety scandal in the Philippines, officials are now considering using the Sanofi vaccine again.

Merck's oncology superstar Keytruda has been stealing the spotlight, but in vaccines, the drugmaker has growth figures to tout.

Experts are pushing for the introduction of J&J's vaccine in the response to the Ebola outbreak in the Democratic Republic of Congo.